Order results by:
| Issue | Title | |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... these drugs, sampeginterferon beta-1a (Tenexia®) was recently approved – an innovative original development ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... of these drugs in the healthcare system of these countries was determined. Sampeginterferon beta-1a itself ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| "... of neurogenesis. The efficiency of treatment is known to be associated with patient medication adherence ..." | ||
| Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
| N. N. Petrova | ||
| "... , highlights the issues of adherence to antidepressant therapy, investigation of the safety and efficacy ..." | ||
| Vol 13, No 4 (2021) | Medication adherence in migraine patients (data of an online survey) | Abstract similar documents |
| N. A. Kovalchuk, E. A. Kiryanova, G. R. Tabeeva | ||
| "... Patient needs, drug intake patterns, and adherence to therapy are significant challenges ..." | ||
| Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
| "... The most important component of the treatment effectiveness is the adherence of patients ..." | ||
| Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
| E. A. Kovalenko, A. N. Bogolepova | ||
| "... Adherence to long-term medication is one of the most important components of effective therapy ..." | ||
| Vol 6, No 3 (2014) | Analysis of reasons for low adherence to antiepileptic therapy in patients with symptomatic epilepsy | Abstract similar documents |
| M. A. Vagina, L. I. Volkova | ||
| "... Objective: to study the major factors that influence treatment adherence. Patients and methods ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... for higher adherence to treatment and its higher efficiency. ..." | ||
| Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
| P. N. Vlasov | ||
| "... ultimately lowers patient adherence to therapy. Pharmaceutical technologies ensuring a delayed release ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... be changing the perception of adverse reactions. This will significantly increase the adherence to therapy ..." | ||
| Vol 6, No 2 (2014) | Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization | Abstract similar documents |
| D.S. Danilov | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... благодаря препаратам, изменяющим течение РС (ПИТРС), которые делятся в зависимости от эффективности на ..." | ||
| Vol 9, No 1 (2017) | Combination therapy for cognitive and emotional impairments in patients with arterial hypertension | Abstract similar documents |
| O. D. Ostroumova, E. A. Karavashkina | ||
| "... with arterial hypertension (AH). It stresses the importance of their correction to improve adherence ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... высокоэффективного препарата, изменяющего течение РС (ПИТРС), но и условия своевременного и безопасного переключения ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... with citicoline is actualized, increasing adherence to therapy by prescribing a convenient form of the drug Noocil ..." | ||
| Vol 6, No 2 (2014) | Posttraumatic stress disorder after stroke: rate, risk factors, approaches to prevention and treatment | Abstract similar documents |
| M.A. Kutlubaev, L.R. Akhmadeeva | ||
| "... in patients after stroke and their adherence to drugs for the secondary prevention of vascular diseases. PTSD ..." | ||
| Vol 14, No 1 (2022) | Kinesiotherapy and non-steroidal anti-inflammatory drugs for nonspecific lumbago | Abstract similar documents |
| A. A. Golovacheva, V. A. Golovacheva, V. A. Parfenov | ||
| "... patients' adherence to kinesiotherapy, relieving pain in the first days of treatment. A specific NSAID ..." | ||
| Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
| E. V. Yakovenko, F. A. Abbasov | ||
| "... and cognitive functions, can significantly improve the quality of life of patients and their adherence ..." | ||
| Vol 13, No 2 (2021) | Drug-induced (medication-induced) depression in neurology practice | Abstract similar documents |
| E. Yu. Ebzeeva, O. D. Ostroumova, S. V. Batyukina, T. M. Ostroumova, A. I. Kochetkov, A. A. Kirichenko | ||
| "... . Its development leads to a decrease in treatment adherence, and in some cases, to discontinuation ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Motor function recovery in patients after ischemic stroke | Abstract similar documents |
| Yu. A. Starchina | ||
| "... treatment (carotid endarterectomy); non-drug treatments (smoking cessation and alcohol abstinence, adherence ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention | Abstract similar documents |
| L.A. Geraskina | ||
| "... of cognitive impairments, which also promotes increased patient treatment adherence and improved poststroke ..." | ||
| Vol 4, No 3 (2012) | The specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease | Abstract similar documents |
| Elena Evgenyevna Vasenina, O S Levin | ||
| "... with a negative effect on the gastrointestinal tract and increases treatment adherence. Thus, there is a rise ..." | ||
| Vol 14, No 5 (2022) | Emotional disorders and their therapy in chronic low back pain | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova, A. Kh. Mukhametzyanova | ||
| "... on dopamine reuptake, interaction with sigma receptors, low incidence of side effects, and high adherence ..." | ||
| Vol 4, No 2 (2012) | Therapy for back pain syndrome | Abstract similar documents |
| E Yu Solovyeva | ||
| "... . To reduce the risk of adverse reactions of NSAID therapy, to enhance its adherence, and to reduce its cost ..." | ||
| Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
| A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
| "... of exhaustion or low mood, which negatively impact adherence and, consequently, treatment efficacy. ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... опережает препараты, изменяющие течение РС (ПИТРС), второй линии натализумаб и финголимод. По клинико ..." | ||
| Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
| V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
| "... назначенных препаратов, изменяющих течение РС (ПИТРС). Пациенты и методы. Проанализированы данные 877 ..." | ||
| Vol 14, No 4 (2022) | Management of patients with subacute back pain: how to effectively prevent chronicity | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, V. A. Parfenov | ||
| "... insufficient adherence to treatment and adherence to medical recommendations. Patient adherence to non-drug ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... , as well as the design of new dosage forms that enhance patient adherence to the prescribed treatment, can ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... increases the adherence of a patient with PD to regular treatment. Two (extended- and immediate-release ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... терапии препаратами, изменяющими течение рассеянного склероза (питрс), или ≥1 обострение и соответствующие ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... (ПИТРС). Изучение новых ПИТРС должно проводиться в строгом соответствии с принципами доказательной ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... (РС), способных усиливать эффект препаратов, изменяющих течение РС (ПИТРС), первой линии. Такое ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... To reduce the risk of developing adverse events (AEs) and increase the adherence of elderly ..." | ||
| Vol 14, No 2 (2022) | Muscular factor in the development of musculoskeletal pain. Treatment options | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova | ||
| "... administration, provide a proven and predictable therapeutic effect, and increase treatment adherence. ..." | ||
| Vol 8, No 4 (2016) | NEUROLOGICAL DISORDERS IN PATIENTS WITH HYPERTENSION AND THEIR CORRECTION | Abstract similar documents |
| N. V. Vakhnina, O. V. Milovanova | ||
| "... to hypertensive patients’ better adherence to long-term antihypertensive therapy, which normalizes blood pressure ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... adherence to CI treatment using newly available dosage forms such as Noocil (240 ml bottle, oral liquid form ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prospects for the use of curcumin as an additional treatment for multiple sclerosis | Abstract similar documents |
| V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko | ||
| "... РС (ПИТРС), второй линии. В связи с этим актуален поиск средств для комплексной терапии РС, способных ..." | ||
| Vol 11, No 1 (2019) | Efficiency of long-term vinpocetine administration in the treatment of dizziness and associated statodynamic disorders in patients with chronic cerebrovascular insufficiency (EDELWEISS study) | Abstract similar documents |
| I. N. Samartsev, S. A. Zhivolupov, Yu. S. Butakova, M. V. Morozova, I. N. Barsukov | ||
| "... -point Likert scale) and increase patient adherence to the therapy performed (on the DAI). The clinically ..." | ||
| Vol 10, No 4 (2018) | Cognitive and motor training for patients with moderate cognitive impairment and mild dementia | Abstract similar documents |
| A. A. Naumenko, I. S. Preobrazhenskaya | ||
| "... of concomitant cardiovascular disease, the degree of apathy, adherence to the training, and the early initiation ..." | ||
| Vol 9, No 2 (2017) | Optimization of the management of patients with nonspecific chronic low back pain | Abstract similar documents |
| E. Yu. Kalimeeva, V. A. Parfenov | ||
| "... months); adherence to the latter remained in most (71.7%) patients. Conclusion. When patients with NCLP ..." | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... of an original dosage form – a 240 ml bottle for oral administration, which improves adherence to long-term ..." | ||
| Vol 15, No 3 (2023) | Safety and tolerability of repetitive transcranial magnetic stimulation: an analysis of over 1200 sessions | Abstract similar documents |
| I. S. Bakulin, A. Kh. Zabirova, A. G. Poydasheva, D. Yu. Lagoda, N. A. Suponeva, M. A. Piradov | ||
| "... remain less well understood but may affect procedure tolerance and treatment adherence. Objective ..." | ||
| Vol 13, No 4 (2021) | Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety | Abstract similar documents |
| E. V. Shikh, Zh. M. Sizova, M. O. Astaeva | ||
| "... provides a higher patient treatment adherence. ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
| A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
| "... disease-modifying therapies indicate the need for close follow-up, adherence control, and psychological ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... patients’ adherence to therapy. ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... patients’ adherence to therapy. ..." | ||
| Vol 16, No 4 (2024) | Chronic neck pain and combined tension headache: a unified effective treatment approach | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... , the patient experienced rapid pain relief, which contributed to adherence to recommendations to increase ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... течение РС (ПИТРС), не получали только 12 (5,1%) пациентов, т. е. в этих случаях препарат назначался как ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... учетом появления большего количества высокоэффективных препаратов, изменяющих течение РС (ПИТРС), а также ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... патогенетической терапии или одного обострения на фоне принимаемых препаратов, изменяющих течение РС (ПИТРС), что ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... другими препаратами, изменяющими течение рассеянного склероза (ПИТРС), в частности с высокодозными ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... течение РС (ПИТРС). Диагноз депрессии определялся в соответствии с критериями МКБ-10. Многофакторные ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... , изменяющих течение РС (ПИТРС), первой линии на вторую линию терапии. Материал и методы. Обследованы 24 ..." | ||
| Vol 2, No 1 (2010) | EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE | Abstract similar documents |
| T. V. Demin, M. V. Saikhunov, D. R. Khasanova | ||
| "... is associated with the adherence to the uniform patient selection criteria and management protocols after TLT ..." | ||
| Vol 14, No 3 (2022) | Combined therapy for Alzheimer's disease | Abstract similar documents |
| V. V. Zakharov, A. V. Lokshina, N. V. Vakhnina | ||
| "... adherence to treatment and limited interaction with caregivers. ..." | ||
| Vol 14, No 6 (2022) | Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents | Abstract similar documents |
| O. D. Ostroumova, A. I. Listratov, T. M. Ostroumova, A. I. Kochetkov, D. A. Sychev | ||
| "... adherence to current recommendations regarding combinations of antithrombotic drugs and protocols ..." | ||
| Vol 16, No 1 (2024) | Alternative and complementary treatments for migraine | Abstract PDF (Eng) similar documents |
| G. R. Tabeeva, E. G. Filatova, A. V. Amelin, V. V. Osipova, A. R. Artemenko, L. R. Akhmadeeva, E. V. Ekusheva, M. I. Koreshkina, E. R. Lebedeva, A. V. Sergeev, V. A. Golovacheva, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, Yu. E. Azimova, A. P. Rachin, V. A. Parfenov | ||
| "... of treatment strategies, and they have good adherence. The basic principles and approaches of CAM ..." | ||
| Vol 15 (2023): (Suppl. 1) | The place of virtual reality in the rehabilitation of patients with multiple sclerosis | Abstract similar documents |
| Iu. E. Korzhova, A. A. Fuks, A. S. Klochkov, A. E. Khizhnikova, N. A. Suponeva, M. N. Zakharova | ||
| "... пациентов с РС шагнула вперед. Однако по-прежнему актуальна проблема приверженности реабилитации. Методы ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Factors influencing the stigmatization of patients with epilepsy | Abstract similar documents |
| I. A. Grigoryeva, L. A. Troitskaya | ||
| "... their stigmatization: individual traits; activity and relations in the group; the effect of a drug and its adherence ..." | ||
| Vol 4, No 2 (2012) | Secondary prevention of ischemic stroke: from recommendations to real clinical practice | Abstract similar documents |
| V A Shandalin, A V Fonyakin, L A Geraskina | ||
| "... приверженность пациентов медикаментозному лечению и регистрировали случаи сердечно-сосудистых осложнений ..." | ||
| Vol 16, No 6 (2024) | Comorbid disorders and their possible prevention in patients with vestibular vertigo | Abstract similar documents |
| O. V. Kosivtsova, Yu. A. Starchina, B. A. Shoev | ||
| "... острого приступа, что позволит предотвратить развитие данных симптомов, повысить приверженность пациентов ..." | ||
| Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... (Церпехол) для приема внутрь, которая может повысить приверженность пациентов лечению и использоваться при ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... постепенным высвобождением один раз в день упрощает схему лечения и повышает приверженность больных терапии. ..." | ||
| Vol 16, No 6 (2024) | Management of patients with cognitive impairment in old age | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Sokolov | ||
| "... форме холина альфосцерата (Церпехол) для приема внутрь, которая может повысить приверженность пациентов ..." | ||
| 1 - 67 of 67 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
